Navigation Links
New "GMO Inside" Campaign Denounces Corporate Disinformation Campaign That Defeated California's Prop 37
Date:11/8/2012

WASHINGTON, Nov. 8, 2012 /PRNewswire-USNewswire/ -- A new coalition, focused on the right to know whether or not foods are genetically engineered, today denounced the millions of dollars poured into anti-Prop 37 efforts by major corporations. The corporate campaign, financed by agribusiness, food and chemical giants such as Monsanto, Dupont, Dow, Coca Cola and Kellogg's, was designed to misinform and deceive the public about the cost of labeling.

"Corporations may have misled voters in California about GMOs, but they can't change the fact that over 90 percent of Americans support the labeling of foods with genetically engineered ingredients," said Alisa Gravitz, CEO of Green America. "The GMO Inside campaign will make it possible for all Americans to find GMOs in the food products in their homes and communities, label them, and switch to non-GMO foods instead.  The campaign will show corporations that people will not complacently serve as lab rats for the testing of genetically engineered foods."

"We are disappointed but not deterred by this defeat," said John W. Roulac, CEO and founder of Nutiva—world's leading organic superfood brand. "GMO Inside was created to catapult the energy from the fight for Prop 37 to the next level. Our goal is to bring greater awareness to consumers nationwide about the dangers of GMOs and educate on what they can do to make a change."

The GMO Inside campaign launched today on Facebook, http://www.facebook.com/GMOInside; Twitter, http://www.twitter.com/GMOInside; and Pinterest, http://www.pinterest.com/GMOInside, and is signing up supporters at www.GMOinside.org.  GMO Inside steering committee members include Food Democracy Now!, Green America, Institute for Responsible Technology, Foodbabe, Nature's Path a
'/>"/>

SOURCE Green America, Washington, D.C.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Mandy Moore Campaigns for Clean Water, GreenBeanBuddy Encourages Mothers to Help Through the Use of Green Cleaning Products
2. Research Triangle Region Debuts Talent Attraction Campaign at BIO 2012
3. UV Flu Technologies to Commence a National TV Advertising Campaign
4. Elsevier Supports International Crisis Aid Through Pillars of Hope Campaign
5. Amgen Names Ray Jordan Senior Vice President, Corporate Affairs
6. BioLife Solutions Completes Corporate Facilities Expansion, Build-Out of Additional cGMP Clean Room Manufacturing Suite
7. Amarantus BioSciences Corporate Overview to be Webcast Live Today from OneMedForum 2012 Conference in NYC
8. QuantRx® Biomedical Provides Corporate Update: Focused on Diagnostics and Feminine Hygiene Segments
9. Computers & Graphics incorporates Collage Authoring Environment
10. Corporate Venturing and Early-Stage Financing in the Spotlight at BioTrinity
11. Mars, Incorporated Answers Question: How Does Feeding People and Pets Nurture Science and Discovery? At TEDMED 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... “PharmaSphere: Emerging Biotech Investment Report Strategic ... report provides in-depth analysis of the current trends ... capital segments of the financial industry, bearing in ... impact on the future of emerging biotechnology companies ... identifies regions of the world that are attracting ...
(Date:7/29/2014)... a particle be separated from its properties? On July ... the results of the first Cheshire Cat experiment, separating ... University in Orange, CA, and Vienna University of Technology. ... a grin," thought Alice in Wonderland, "but a grin ... ever saw in my life!" Alice,s surprise stems from ...
(Date:7/29/2014)... July 29, 2014 Second generation biofuels are ... by fossil fuels. However, as natural gas is very cheap, ... they are not as valuable as they could be in ... difficulty financing projects, has made it difficult for renewable energy ... get off the ground. For these reasons, certain companies have ...
(Date:7/29/2014)... SPRINGS, Colo. , July 29, 2014 /PRNewswire/ ... specializing in cannabis formulation-based drug development and related ... York Times for taking a strong position in ... its Sunday, July 27, 2014 publication.  The New ... editorials and articles this week exploring the issue ...
Breaking Biology Technology:Strategic Trends of Biotech Investment Industry (Private Equity and Venture Capital Funding) in New Report Available at MarketOptimizer.org 2Strategic Trends of Biotech Investment Industry (Private Equity and Venture Capital Funding) in New Report Available at MarketOptimizer.org 3Strategic Trends of Biotech Investment Industry (Private Equity and Venture Capital Funding) in New Report Available at MarketOptimizer.org 4The quantum Cheshire cat: Scientists separate a particle from its properties 2The quantum Cheshire cat: Scientists separate a particle from its properties 3The quantum Cheshire cat: Scientists separate a particle from its properties 4Renewable Waste Intelligence: Could Renewable Chemicals Be the Future for the Renewable Energy Industry? 2Cannabis Science, Inc. (CBIS) Applauds New York Times Editorial Board Stance on 'Repealing Prohibition, Again'; NYT Editorial Is Bell Weather of Change 2Cannabis Science, Inc. (CBIS) Applauds New York Times Editorial Board Stance on 'Repealing Prohibition, Again'; NYT Editorial Is Bell Weather of Change 3
... Incorporated (Nasdaq: ARAY ), a global leader in ... results for its second quarter of fiscal 2011, ended December ... closes. A conference call to review the results ... be hosted by Euan S. Thomson, Ph.D., president and chief ...
... Registration is now open for StemCONN 2011. ... in stem cell research, will take place Tuesday, March ... session) and the UConn Health Center (commercial session and ... at http://stemconn.org/ . StemCONN 2011 will ...
... Md., Jan. 13, 2011 Celsion Corporation (Nasdaq: ... to the development and commercialization of innovative oncology drugs, ... securities purchase agreement with a select group of institutional ... to sell 5,000 shares of 8% redeemable convertible preferred ...
Cached Biology Technology:Accuray Incorporated to Report Financial Results for Second Quarter of Fiscal 2011 2Celsion Corporation Announces Convertible Preferred Stock Financing and Amended License Agreement for Aggregate Gross Proceeds of up to $9 Million 2Celsion Corporation Announces Convertible Preferred Stock Financing and Amended License Agreement for Aggregate Gross Proceeds of up to $9 Million 3Celsion Corporation Announces Convertible Preferred Stock Financing and Amended License Agreement for Aggregate Gross Proceeds of up to $9 Million 4
(Date:7/29/2014)... (UM SOD) and Medicine (UM SOM) jointly announced ... million grant award from the National Institute of ... Institutes of Health to study the causes, prevention ... which renews a previous $12 million five-year NIAID-funded ... research by studying chlamydial and gonorrheal diseases as ...
(Date:7/29/2014)... to go and almost 2500 registered participants, the final ... The event, a joint venture between the Federation of ... for Biochemistry and Molecular Biology (SFBBM), will take place ... the Palais des Congrs in Paris, France. , The ... life sciences in Europe this year. It features more ...
(Date:7/29/2014)... it affects 1 in 100,000 people characterized by ... its cause remains unknown, a new study by a team ... Bonn in Germany and other European institutions confirms for the ... published on 6 July in Nature Genetics , is ... we swallow, a sphincter in the lower esophagus opens, allowing ...
Breaking Biology News(10 mins):University of Maryland Schools of Dentistry and Medicine receive NIH grant 2University of Maryland Schools of Dentistry and Medicine receive NIH grant 3University of Maryland Schools of Dentistry and Medicine receive NIH grant 4Counting down to FEBS-EMBO 2014 in Paris, France 2Mysterious esophagus disease is autoimmune after all 2
... from reducing cholesterol and having anticancerogenic properties, is characterised ... which genes are responsible for this activity ?the reason ... agent, was the aim of the PhD thesis by ... University of Navarre with the title, Molecular Characterisation of ...
... National Institutes of Health (NIH) announced today a new ... articles resulting from NIH-funded research. The policy ?the first ... release to the public manuscripts from research supported by ... of final publication. , These peer-reviewed, NIH-funded research publications ...
... harmless on human skin, but it is the ... indwelling medical devices. S. epidermidis is associated with ... prosthetic joints, replacement heart valves, and intravenous catheters, ... Moreover, the mechanism through which the organism becomes ...
Cached Biology News:Advances in the characterisation of the oyster mushroom genes 2NIH Calls on Scientists to Speed Public Release of Research Publications 2NIH Calls on Scientists to Speed Public Release of Research Publications 3
Purified Mouse anti-Hu LAT (pY226) Storage Temperature: Refrigerate(2 to 8C)...
Tris-EDTA Buffer Solution, 1X, pH 8.0, sterile, Molecular Biology Grade...
... the most comprehensive, cost-effective solution to ... incorporated unprecedented quality into both our ... proven detection chemistries and antibodies that ... protocol. It also includes our competitively ...
...
Biology Products: